{"product_id":"brukinsa-zanubrutinib","title":"BRUKINSA (Zanubrutinib)","description":"\u003cp\u003eBRUKINSA (Zanubrutinib) sold under the brand name 百悦泽 in china, is a BTK Inhibitor used to treat adults with:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eChronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL).\u003c\/li\u003e\n\u003cli\u003eWaldenström’s macroglobulinemia (WM).\u003c\/li\u003e\n\u003cli\u003eMantle cell lymphoma (MCL) who have received at least one prior treatment for their cancer.\u003c\/li\u003e\n\u003cli\u003eMarginal zone lymphoma (MZL) when the disease has come back or did not respond to treatment and who have received at least one certain type of treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eZanubrutinib was approved by FDA for medical use in the United States in November 2019.\u003c\/p\u003e\u003cp\u003eAs of November 17, 2023, Zanubrutinib was approved for medical use in 44 countries around the world.\u003c\/p\u003e","brand":"BeiGene Biotechnology, China","offers":[{"title":"Default Title","offer_id":44797952065579,"sku":"RL23202402","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2024-01-2228.png?v=1787022166","url":"https:\/\/xomeds.com\/products\/brukinsa-zanubrutinib","provider":"XOMEDS","version":"1.0","type":"link"}